LIGAND PHARMACEUTICALS (LGND:NASDAQ)
$263.46 8.21 (3.2165%)
Analysed LIGAND PHARMACEUTICALS (LGND:NASDAQ) News Sources
Ligand Pharmaceuticals' (NASDAQ:LGND) Strong Earnings Are Of Good Quality
15-05-2026
yahoo.com
Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?
16-05-2026
fool.com
Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million?
19-05-2026
fool.com
Ligand to Participate in June Investor Conferences
27-05-2026
yahoo.com
OneSpaWorld Posted Record Revenue for Last Quarter. Why Did a Fund Exit a $21.5 Million Stake?
29-05-2026
fool.com
Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy?
30-05-2026
fool.com
How The Ligand Pharmaceuticals (LGND) Investment Story Is Evolving Without Fresh Analyst Targets
01-06-2026
yahoo.com
A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million
07-06-2026
fool.com
Ligand Announces 2026 Investor Day in New York City
10-06-2026
yahoo.com
Ligand Pharmaceuticals Director Unloads 2,501 Shares — Should You Be Concerned?
14-06-2026
fool.com
What is the current price of LIGAND PHARMACEUTICALS (LGND:NASDAQ)?
The current price of LIGAND PHARMACEUTICALS (LGND:NASDAQ) is $263.46.
LIGAND PHARMACEUTICALS (LGND:NASDAQ) absolute price change since previous trading day?
The absolute price change of LIGAND PHARMACEUTICALS (LGND:NASDAQ) since the previous trading day is $8.21.
LIGAND PHARMACEUTICALS (LGND:NASDAQ) percentage price change since previous trading day?
The percentage price change of LIGAND PHARMACEUTICALS (LGND:NASDAQ) since the previous trading day is 3.2165%.
What is the most recent average sentiment score for LIGAND PHARMACEUTICALS (LGND:NASDAQ)?
The most recent average sentiment score for LIGAND PHARMACEUTICALS (LGND:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for LIGAND PHARMACEUTICALS (LGND:NASDAQ)?
The most recent sentiment for LIGAND PHARMACEUTICALS (LGND:NASDAQ) is .
SEC-8K** Filing Available For LIGAND PHARMACEUTICALS (LGND:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.